Hospital Clinico Universitario De Valencia — Clinical Trial Site

650 Registered trials

267 Currently recruiting

Organisation

Hospital Clinico Universitario De Valencia

Location

Valencia, Spain

Identifier

ORG-100032606

Address

Avenida Blasco Ibanez 17, 46010, Spain

Departments

#034004 Oncología
#1403: Oncología
#2318:servicio de neurología
#2503: Oncología Médica
#4004:Hematología
#4213:Servicio de Endocronología y Nutrición
#4503: Cardiología
#7003: Oncología Medica
#7005:Oncology
#8004: Oncología Médica
#9005: Oncology
034-05: Oncologia Médica y Hematologia
03405:Oncologia Médica y Hematologia
1203:Oncología Médica
1304: Oncología
1317: Oncologia Médica y Hematologia
1603:Oncología
2404: Reumatología
2404:Rheumatology
2601: Cardiology
2605:Urology
2803: Cardiologia
3102: Oncología.
3106: neurologia
3150: Cardiología
3278:Urologia
3307: Oncologia
3502: Cardiologia
5509: Neumologia
7002
7005: Oncology
7006: Oncología
7006: Oncologia Médica y Hematologia
7006:Oncología
7007; Oncology
7010: Anestesiología y Reanimación
724005: Oncologia Médica y Hematologia
9404:Oncologia Médica y Hematologia
ALERGOLOGÍA
Allergology
Anaesthesia Department
Anaesthesia. Resuscitation and Pain Unit
Anestesia
Anestesiología y Reanimación
Anesthesia
Anesthesiology
Anesthesiology and Reanimation
Aparato Digestivo
Cardiologia
Cardiology
Cardiology department
Cirugía
Clinical Haematology
Department of Anesthesiology and Surgical-Trauma Intensive Care
Department of Hematology
Department of Hematology and Medical Oncology
Department of Neurology
Dermatology
Digestive
Digestive Department
Digestive Medicine
Endocrinología
Endocrinology
Endocrinology and metabolism
Ensayos Clinicos
ES10007: Gastroenterologia
ESP0604: Oncologia Médica y Hematologia
Gastroenterology
Gastroenterology and Hepatology
General Surgery
Haematology
Hematologia
Hematología y Hemoterapia/ Hematology and Hemotherapy
Hematología y Oncología
Hematology
Hematology & Hemotherapy
Hematology and Medical Oncology
Hematology and Medical Oncology Service
Hematology and Oncology
Hematology Department
Hematology Service
Hematology Service and Hemotherapy Service
Hepatología
Hepatology Service
Hospital Clínico Universitario
Hospital Clínico Universitario de Valencia
INCLIVA - Biomedical Research Institute
INCLIVA Biomedical Research Institute. Hospital Clínico Universitario of Valencia
Infectious Diseases
Instituto de Investigación Sanitaria INCLIVA
Intensive Medicine
Internal Medicine
Interventional Cardiology
Materno Infantil - Servicio Oncologia
Medica Oncology
Medical Doctor
Medical Oncology
Medical Oncology and Hematology
Medical Oncology Department
Medical Oncology Service
Medical Oncology, Phase I Unit
Medicina Digestiva
Medicine
Medidla oncologist
n/a
NA
Nefrologia
Nefrology
Nephrology
Nephrology Service
Nesthesiology
Neumologia
Neumology
Neurología
Neurology
Onclogy
Oncología
Oncologia Medica
Oncologia Médica y Hematologia
Oncología y Hematología
Oncology
Oncology and Hematology
Oncology and Medical Hematology
Oncology Department
Oncology service
Oncology Service Department
Oncology Service.
Onology
Pain Unit
Pediatría
Pediatric Oncology and Hematology
Pediatric oncology and hematology department
Pediatric oncology department
Pediatríc Unit
Phase I and Precision Medicine Unit
Pneumology
Pneumology Department
Pneumology Service
Psychiatry Department
Pulmonology
Respiratory medicine
Rheumatologist
Rheumatology
Sempere
Servicio de digestivo
Servicio Cardiología
Servicio de Cardiología
Servicio de Digestivo
Servicio de Endocrinologia
Servicio de endocrinologia y nutricion
Servicio de Hematologia
Servicio de Hematología y Oncología
Servicio de Hematología y Oncología Médica
Servicio de Hematologia y Oncologia, INCLIVA. Edificio Maternidad.
Servicio de Neumología
Servicio de Oncología
Servicio de Oncología Médica
Servicio de Oncología Médica y Hematología
Servicio de Reumatología
Servicio Neumologia
Servicio Oncología
Stroke Unit
Unidad del Dolor dentro del departamento SARTD
Urology

Clinical trials at this site (650)

Search interface

Integrated PK/efficacy, safety, and immunogenicity study to demonstrate similarity of JPB898, a proposed biosimilar to nivolumab, to Opdivo®… Ended

2023-507865-24-00 Advanced (unresectable/metastatic) melanoma 5 2025-03-28
AKTive-001: A Phase 1/1b Multiple Cohort Trial of ALTA2618 in Patients with Advanced Solid Tumors with AKT1 E17K Mutation Ended

2024-515391-12-00 Advanced Solid Tumors with AKT1 E17K Mutation 1 2025-03-15
A Study of ZL-1218 with or without Pembrolizumab in Subjects with Advanced Solid Tumor Cancers to Find a Suitable Dose and to Test How Diffe… Ended

2022-503102-20-00 Advanced solid tumors 1 2025-03-10
N/A Ended

2024-513121-22-00 Recurrent or Metastatic Head and Neck Squamous Cell Car 4 2025-02-04
Phase 2 Study of BB-1701 in HER2 positive or HER2-low metastatic breast cancer Ended

2023-506866-30-00 HER2 positive or HER2-low metastatic breast cancer 4 2024-08-19
A study to learn about how well a new drug called BAY3283142 works and how safe it is in reducing albumin in the urine of people with chroni… Ended

2023-505755-40-00 Chronic kidney disease 4 2024-08-16
A dose-finding trial with LU AG90222 in adults with migraine who have not been helped by prior preventative treatments. Ended

2023-508821-28-00 Migraine 4 2024-08-14
A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma Ended

2023-507324-23-00 recurrent or persistent uterine serous carcinoma 4 2024-05-22
Phase I/II randomized trial of LB-100 plus doxorubicin vs. doxorubicin alone in first line of advanced soft tissue sarcomas Ended

2024-510877-67-00 Phase I:Adult patients with centrally confirmed diagnos 8 2024-05-14
A study to learn how safe starting vericiguat at a dose of 5 milligrams is in participants with chronic heart failure with reduced ejection … Ended

2023-507682-25-00 Chronic heart failure with reduced ejection fraction 4 2024-05-13
To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination W… Ended

2023-508124-36-00 Advanced or metastatic breast cancer and other advanced 1 2024-05-10
Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery Ended

2023-507009-32-00 General anaesthesia 5 2024-05-08
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without T… Ended

2023-504583-42-00 Overweight or Obesity and Chronic Kidney Disease With o 4 2024-05-07
First-in-Human Study of TAK-280 in Participants With Unresectable Locally Advanced or Metastatic Cancer Ended

2023-504012-16-00 Unresectable Locally Advanced or Metastatic Cancer 7 2024-04-29
A clinical research study to learn if baxdrostat works at reducing ambulatory blood pressure and is safe for people with high blood pressure… Ended

2023-507640-36-00 Resistant hypertension (rHTN) defined as blood pressure 5 2024-04-29
MYK-224 in Heart Failure with Preserved Ejection Fraction (HFpEF) Ended

2023-505919-21-00 Heart failure with preserved ejection fraction (HFpEF) 4 2024-04-25
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) Ended

2022-502899-23-00 Hepatic Encephalopathy (OHE) 5 2024-04-23
A research study to see if kidney damage in people with chronic kidney disease and type 2 diabetes living with overweight or obesity can be … Ended

2023-505857-42-00 Chronic Kidney Disease, Type 2 diabetes 4 2024-04-19
MLS-101-301: A Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of … Ended

2023-506425-12-00 Uncontrolled and Resistant Hypertension 5 2024-04-17
FIH study of ALE.C04 anti-CLDN1 mAb monotherapy or in combination with pembrolizumab in patients with R/M HNSCC Ended

2023-505145-93-00 Recurrent or Metastatic (R/M) Head and Neck Squamous Ce 7 2024-03-21
A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors Ended

2023-504824-24-00 Arm A: Diagnosed with uterine serous carcinoma (USC) Ar 3 2024-03-15
A proof of concept and dose-finding study of XXB750 in patients with heart failure Ended

2023-504678-39-00 Heart Failure 4 2024-03-13
Dose-response characterization of VER-01 in the treatment of patients with chronic non-specific low back pain Ended

2023-507358-34-00 For the treatment of patients with chronic non-specific 4 2024-02-13
MK-0616-013 Ended

2022-502777-42-01 Hypercholesterolemia 5 2024-01-16